The corresponding 2-month probability of survival was 45% (95% CI, 32-56) and 53% (95% CI, 47-60), respectively; that is, there was a nonsignificant trend toward better survival, whereas survival after 6-month and 12-month was not significantly different ( Table 2 ).
← all excerpts
Malignancy-associated hemophagocytic lymphohistiocytosis in Sweden: incidence, clinical characteristics, and survival.
1
—
—